Clinical Trials for Brain Tumors

Visit our Specialty Center

A clinical trial is a research study that offers carefully selected brain tumor patients access to advanced treatments not yet part of standard care — such as new chemotherapy drug formulations, immunotherapy that harnesses the body’s own immune system, and gene therapy targeting the tumor’s genetic makeup.

The division of neuro-oncology is actively involved in research to advance the treatment of gliomas and other brain tumors. Clinical trials are offered to carefully selected patients and serve as an adjunct to standard of care. These innovative treatments include novel preparations of chemotherapeutic drugs designed to bypass physiological barriers. Immunotherapy, harnessing the patient’s own immune system to fight cancer is another mechanism that has been developed to treat brain cancer and involves the administration of vaccines directed to brain tumors. Treatment paradigms based on the manipulation of the brain tumor genome-gene therapy is also offered to broaden the opportunity for oncologic control.

Frequently Asked Questions (FAQs) About Clinical Trials for Brain Tumors

What types of clinical trials are available for brain tumors?

Options include novel chemotherapy drug preparations designed to bypass physiological barriers, immunotherapy that uses the patient's own immune system, and gene therapy targeting the tumor's genetic makeup.

Who is eligible for a clinical trial?

Trials are offered to carefully selected patients as an adjunct to standard care; eligibility depends on the specific trial and the patient's individual case.

Have More Questions about This Condition

Visit our Neuro-Oncology and Skull-Base Surgery Specialty Center